We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
+$8.65B
Cap. Flow %
5.19%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,244
Increased
2,720
Reduced
2,447
Closed
981

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Financials 6.67%
3 Healthcare 6.18%
4 Industrials 4.97%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTAA
6376
CALL
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
$103K ﹤0.01%
79,384
+61,692
+349% +$609K
DMYQ.U
6377
DELISTED
dMY Technology Group, Inc. IV Units, each consisting of one share of Class A common stock and one-fi
DMYQ.U
$103K ﹤0.01%
10,000
-430,000
-98% -$4.39M
CTEV
6378
CALL
Claritev Corp
CTEV
$402M
$102K ﹤0.01%
1,813
NBSE
6379
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$102K ﹤0.01%
1,410
-7,291
-84% -$558K
CO
6380
DELISTED
Global Cord Blood Corporation
CO
$102K ﹤0.01%
21,800
-6,712
-24% -$32.9K
MCHX icon
6381
Marchex
MCHX
$78M
$101K ﹤0.01%
33,816
+9,898
+41% +$28.9K
CTHR
6382
DELISTED
Charles & Colvard Ltd
CTHR
$101K ﹤0.01%
3,386
-11,899
-78% -$330K
ADOC
6383
DELISTED
Edoc Acquisition Corp. Class A Ordinary Share
ADOC
$101K ﹤0.01%
10,000
FTCVW
6384
CALL
DELISTED
FinTech Acquisition Corp. V Warrant
FTCVW
$101K ﹤0.01%
48,166
ETACW
6385
CALL
DELISTED
E.Merge Technology Acquisition Corp. Warrant
ETACW
$101K ﹤0.01%
+143,916
New +$119K
MITAU
6386
DELISTED
Coliseum Acquisition Corp. Unit
MITAU
$100K ﹤0.01%
10,000
-152,500
-94% -$1.51M
EMBKW
6387
CALL
DELISTED
Embark Technology, Inc. Warrants
EMBKW
$100K ﹤0.01%
+93,333
New +$118K
VENAR
6388
CALL
DELISTED
Venus Acquisition Corporation Rights
VENAR
$100K ﹤0.01%
10,000
AMPI.WS
6389
CALL
DELISTED
Advanced Merger Partners Inc Warrants
AMPI.WS
$100K ﹤0.01%
111,054
+8,189
+8% +$8.42K
TURN
6390
DELISTED
180 Degree Capital
TURN
$99K ﹤0.01%
+13,678
New +$103K
VIOT
6391
Viomi Technology
VIOT
$50.9M
$99K ﹤0.01%
21,685
-47,285
-69% -$266K
VSA
6392
VisionSys AI
VSA
$8.16M
$99K ﹤0.01%
29
-10
-26% -$46.2K
SFRWW
6393
CALL
DELISTED
Appreciate Holdings, Inc. Warrant
SFRWW
$99K ﹤0.01%
116,666
+75,000
+180% +$69.3K
OSI.U
6394
DELISTED
Osiris Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant
OSI.U
$99K ﹤0.01%
10,000
-1,990,000
-100% -$19.8M
ATXI
6395
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$98K ﹤0.01%
59
-6
-9% -$12.4K
MKFG.WS
6396
CALL
DELISTED
Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share
MKFG.WS
$98K ﹤0.01%
+72,353
New +$117K
BIOT
6397
CALL
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$98K ﹤0.01%
148,000
+48,000
+48% +$465K
AFI
6398
DELISTED
Armstrong Flooring, Inc.
AFI
$98K ﹤0.01%
31,371
-25,565
-45% -$105K
IRIX icon
6399
IRIDEX
IRIX
$14.5M
$97K ﹤0.01%
12,712
-40,786
-76% -$286K
BRIVW
6400
CALL
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$97K ﹤0.01%
+138,335
New +$129K

Similar funds

Millennium Management's Q3 2021 Portfolio in Review

As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $694M trimmed.

  • Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
  • Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.